Search Results - "Arbeeny, C M"

Inhibition of fatty acid synthesis decreases very low density lipoprotein secretion in the hamster by Arbeeny, CM, Meyers, DS, Bergquist, KE, Gregg, RE

“…The hamster was developed as a model to study very low density lipoprotein (VLDL) metabolism, since, as is the case in humans, the hamster liver was found to…”
Get full text

The uptake of chylomicron remnants and very low density lipoprotein remnants by the perfused rat liver by Arbeeny, C M, Rifici, V A

“…The regulation of the hepatic uptake of chylomicron remnants and very-low-density lipoprotein (VLDL) remnants was studied in the rat using a nonrecirculating…”
Get full text

Colloidal Gold-Low Density Lipoprotein Conjugates as Membrane Receptor Probes by Handley, Dean A., Arbeeny, Cynthia M., Witte, Larry D., Chien, Shu

“…We have developed a method for conjugating low density lipoproteins (LDL) with colloidal gold. Conjugation, complete after 1 min, occurs by electrostatic…”
Get full text

Metabolic alterations associated with the antidiabetic effect of beta 3-adrenergic receptor agonists in obese mice by Arbeeny, C.M, Meyers, D.S, Hillyer, D.E, Bergquist, K.E

“…Treatment of obese (ob/ob) mice with the beta3-adrenergic receptor (beta3-AR) agonist BRL35135 (1 mg.kg body wt-1.day-1 for 20 days) normalized plasma glucose…”
Get full text

Effects of hyperlipidemias in hamsters on lipid transfer protein activity and unidirectional cholesteryl ester transfer in plasma by Quig, D W, Arbeeny, C M, Zilversmit, D B

“…Experiments were performed to characterize plasma lipid transfer protein activity (LTA), and the rate of [3H]CE transfer from HDL to lower density lipoproteins…”
Get more information

BMS-201620: a selective beta 3 agonist by Washburn, W.N., Sun, C.-Q., Bisacchi, G., Wu, G., Cheng, P.T., Sher, P.M., Ryono, D., Gavai, A.V., Poss, K., Girotra, R.N., McCann, P.J., Mikkilineni, A.B., Dejneka, T.C., Wang, T.C., Merchant, Z., Morella, M., Arbeeny, C.M., Harper, T.W., Slusarchyk, D.A., Skwish, S., Russell, A.D., Allen, G.T., Tesfamariam, B., Frohlich, B.H., Abboa-Offei, B.E., Cap, M., Waldron, T.L., George, R.J., Young, D., Dickinson, K.E., Seymour, A.A.

“…Graphic A series of N-(4-hydroxy-3-methylsulfonanilidoethanol)arylglycinamides were prepared and evaluated for their human β 3 adrenergic receptor agonist…”
Get full text

The uptake of the apoprotein and cholesteryl ester of high-density lipoproteins by the perfused rat liver by Arbeeny, C M, Rifici, V A, Eder, H A

“…The uptake of the 125I-labeled apolipoprotein and 3H-labeled cholesteryl ester components of rat apolipoprotein E-deficient HDL by the perfused liver was…”
Get more information

Effects of fish oil on glomerular function in rats with diabetes mellitus by Sinha, AK, Scharschmidt, LA, Neuwirth, R, Holthofer, H, Gibbons, N, Arbeeny, CM, Schlondorff, D

“…The mechanisms responsible for hyperfiltration in diabetes mellitus (DM) as well as for the initiation and progression of diabetic nephropathy are not fully…”
Get full text

Serum lipoproteins of diabetic rats fed a high cholesterol diet by Arbeeny, C M, Edelstein, D, Freedman, S R, Eder, H A

“…Serum lipoproteins of diabetic rats fed a high cholesterol diet. C M Arbeeny , D Edelstein , S R Freedman and H A Eder Abstract Feeding a diet containing 2%…”
Get full text

Removal of lipid-rich lipoproteins by the liver by Arbeeny, C.M, Eder, H.A

“…Studies were performed to determine the mechanism of hepatic removal of a cholesterol-rich beta-migrating lipoprotein. This fraction, designated IDLc, was…”
Get full text

BMS-196085 : A potent and selective full agonist of the human β3 adrenergic receptor by GAVAI, A. V, SHER, P. M, WANG, T. C, SUN, C. Q, SLUSARCHYK, D. A, SKWISH, S, ALLEN, G. T, HILLYER, D. E, FROHLICH, B. H, ABBOA-OFFEI, B. E, CAP, M, WALDRON, T. L, MIKKILINENI, A. B, GEORGE, R. J, TESFAMARIAM, B, HARPER, T. W, CIOSEK, C. P, YOUNG, D. A, DICKINSON, K. E, SEYMOUR, A. A, ARBEENY, C. M, WASHBURN, W. N, POSS, K. M, MCCANN, P. J, GIROTRA, R. N, FISHER, L. G, WU, G, BEDNARZ, M. S, MATHUR, A

Get full text

Hepatic Binding and Internalization of Low Density Lipoprotein-Gold Conjugates in Rats Treated with 17α-Ethinylestradiol by Handley, A., Arbeeny, Cynthia M., Eder, Howard A., Chien, Shu

“…Receptor-mediated hepatic uptake of low density lipoproteins (LDL) conjugated to colloidal gold was studied by perfusion of livers from rats treated for 5 d…”
Get full text

Effects of 17 alpha-ethinyl estradiol on the serum lipoproteins of cholesterol-fed diabetic rats by Arbeeny, C M, Eder, H A

“…Large doses of 17 alpha-ethinyl estradiol were administered to rats made diabetic by administration of streptozotocin and fed a diet containing 2% cholesterol…”
Get full text

Effect of diabetes on the metabolism of triacylglycerol-rich lipoproteins by Arbeeny, C M, Eder, H A

Get more information

Hyperlipoproteinemia in spontaneously diabetic guinea pigs by Arbeeny, C M, Nordin, C, Edelstein, D, Stram, N, Gibbons, N, Eder, H A

“…A colony of Hartley guinea pigs that exhibit hyperglycemia, glucosuria, and hypertriglyceridemia characteristic of human diabetes mellitus was developed…”
Get more information

Sinusoidal endothelial endocytosis of low density lipoprotein-gold conjugates in perfused livers of ethinyl-estradiol treated rats by Handley, D A, Arbeeny, C M, Chien, S

“…We examined endocytosis of low-density lipoproteins (LDL) conjugated to colloidal gold by the sinusoidal endothelium in perfused livers of 17 alpha-ethinyl…”
Get more information

Effect of platelet activating factor on endothelial permeability to plasma macromolecules by Handley, D A, Arbeeny, C M, Lee, M L, Van Valen, R G, Saunders, R N

“…We have examined the effect of intrajugular administration of platelet activating factor (PAF-C16) on vascular permeability in the guinea pig. To examine the…”
Get more information

Determinants of the uptake of very low density lipoprotein remnants by the perfused rat liver by Arbeeny, C M, Rifici, V A, Handley, D A, Eder, H A

“…The receptor-mediated uptake of very low density lipoprotein (VLDL) remnants by the rat liver was studied. Livers were perfused with native 125I-VLDL remnants,…”
Get more information

BMS-196085: a potent and selective full agonist of the human beta(3) adrenergic receptor by Gavai, A V, Sher, P M, Mikkilineni, A B, Poss, K M, McCann, P J, Girotra, R N, Fisher, L G, Wu, G, Bednarz, M S, Mathur, A, Wang, T C, Sun, C Q, Slusarchyk, D A, Skwish, S, Allen, G T, Hillyer, D E, Frohlich, B H, Abboa-Offei, B E, Cap, M, Waldron, T L, George, R J, Tesfamariam, B, Harper, T W, Ciosek, Jr, C P, Young, D A, Dickinson, K E, Seymour, A A, Arbeeny, C M, Washburn, W N

“…A series of 4-hydroxy-3-methylsulfonanilido-1,2-diarylethylamines were prepared and evaluated for their human beta(3) adrenergic receptor agonist activity. SAR…”
Get full text

The effect of pravastatin on serum cholesterol levels in hypercholesterolemic diabetic rabbits by Arbeeny, C M, Bergquist, K E

“…Diabetes mellitus is associated with hyperlipidemia and increased risk of atherosclerosis. A diabetic animal model has been developed to study the effect of…”
Get more information